# FDA Inspection 1200707 - Biomat USA, Inc. - March 09, 2023

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d385247d-9fe9-443b-8dc6-5a4780a37dcf
Source feed: FDA_Inspections

> FDA Inspection 1200707 for Biomat USA, Inc. on March 09, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200707
- Company Name: Biomat USA, Inc.
- Inspection Date: 2023-03-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1200707 - 2023-03-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/154490ea-cf61-4a6b-a89e-3158d1c871a5)
- [FDA Inspection 1039877 - 2017-12-28](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1cb89677-adff-44c3-8850-30e1a7fe1160)

Company: https://www.keypedia.com/companies/biomat-usa-inc/188d32e7-de05-4cdc-8709-743eb80e676f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d